A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific T h 1 cells

By Sato M.   Chamoto K.   Nishimura T.  

International Immunology, Vol. 15, Iss. 7, 2003-07 ,pp. : 837-843

Oxford University Press

Access to resources Recommend Favorite

Adjuvant-dependent modulation of T h 1 and T h 2 responses to immunization with -amyloid

By Cotman C.W.  

International Immunology, Vol. 15, Iss. 4, 2003-04 ,pp. : 505-514

Oxford University Press

Access to resources Recommend Favorite

Potent Systemic Antitumor Immunity Induced by Vaccination with Chemotactic-Prostate Tumor Associated Antigen Gene-Modified Tumor Cell and Blockade of B7-H1

By LI NING   QIN HANJUN   LI XIAOZHU   ZHOU CHUNXIA   WANG DONGMEI   MA WENBO   LIN CHEN   ZHANG YOUHUI   WANG SHENGDIAN   ZHANG SHUREN  

Journal of Clinical Immunology, Vol. 27, Iss. 1, 2007-01 ,pp. : 117-130

Springer Publishing Company

Access to resources Recommend Favorite

T h 1 versus T h 2 cytokine profile determines the modulation of in vitro T cell-independent type 2 responses by IL-4

By Snapper C.M.   Vos Q.   Mond J.J.  

International Immunology, Vol. 12, Iss. 9, 2000-09 ,pp. : 1337-1345

Oxford University Press

Access to resources Recommend Favorite

Tumor cell expression of HLA-DM associates with a T h 1 profile and predicts improved survival in breast carcinoma patients

By Oldford Sharon A.   Robb J. Desmond   Codner Dianne   Gadag Veeresh   Watson Peter H.   Drover Sheila  

International Immunology, Vol. 18, Iss. 11, 2006-11 ,pp. : 1591-1602

Oxford University Press

Access to resources Recommend Favorite